DCAT Value Chain Insights

Tracking Parenteral Drugs in New Drug Approvals

The number of parenteral drugs in the industry's pipeline and recently approved new drugs continues to rise with the increase of biologics and more complex active pharmaceutical ingredients. DCAT...

FDA, FTC Join To Increase Biologic Drug Competition

The FDA and FTC are collaborating to advance market competition in biologics, including for biosimilars. What have the agencies done thus far and what are they planning to do? The US market for...

Future focus: Our 2020 vision

Information
February 11, 2020
Sponsored by Cambrex

Cambrex eBook: The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021, driven by positive industry trends — many of which our experts commented on in Part 1...

Read More
Small Molecules: 2020 Vision

Information
January 31, 2020
Sponsored by Cambrex

Cambrex experts have contributed more articles to our biggest eBook yet. The industry trend of outsourcing to CDMOs continues. With more services, capabilities, facilities and employees than ever...

Read More
Digital Transformation in 2020: What Should Pharma Know?

Information
January 6, 2020
Sponsored by LabVantage

To extract continuous value from R&D activities and ensure manufacturing quality, pharmaceutical companies are – or should be – embracing digital transformation. This business journey uses...

Read More